Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/13/2025 | $15.00 | Buy | BofA Securities |
| 3/17/2025 | $15.00 → $12.00 | Sell → Neutral | UBS |
| 3/4/2025 | $26.00 → $16.00 | Buy → Hold | TD Cowen |
| 2/4/2025 | $20.50 → $15.00 | Neutral → Sell | UBS |
| 11/11/2024 | $27.00 → $26.00 | Buy | TD Cowen |
| 10/17/2024 | $22.00 → $27.00 | Buy | TD Cowen |
| 8/12/2024 | $20.00 → $18.00 | Buy | TD Cowen |
| 8/18/2022 | $14.00 → $23.00 | Neutral → Buy | Goldman |
BofA Securities initiated coverage of Calumet Specialty Products with a rating of Buy and set a new price target of $15.00
UBS upgraded Calumet Specialty Products from Sell to Neutral and set a new price target of $12.00 from $15.00 previously
TD Cowen downgraded Calumet Specialty Products from Buy to Hold and set a new price target of $16.00 from $26.00 previously
4 - Calumet, Inc. /DE (0002013745) (Issuer)
4 - Calumet, Inc. /DE (0002013745) (Issuer)
4 - Calumet, Inc. /DE (0002013745) (Issuer)
144 - Calumet, Inc. /DE (0002013745) (Subject)
144 - Calumet, Inc. /DE (0002013745) (Subject)
8-K - Calumet, Inc. /DE (0002013745) (Filer)